Some studies have suggested that changes in SEPN1 expression might serve as a marker for the progression of colorectal adenomas to cancer [53], and SEPN1 was upregulated in the HepG2 liver cancer cell line compared to the normal liver cell line LO2 [54]. This evidence concerns the gene SELENON and liver cancer.